{
  "paper_metadata": {
    "pmid": "34504103",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted two BRCA2 variants with clinical significance, penetrance data, and functional information."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1813dup",
      "protein_notation": "p.(Ile605Asnfs*11)",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "33-year-old female",
        "phenotype": "Fanconi anemia, breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "FA663",
          "age_at_evaluation": 33,
          "age_at_onset": null,
          "age_at_diagnosis": 33,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with Fanconi anemia after chemotherapy reaction",
          "evidence_sentence": "Patient FA663 was a thirty-three-year-old woman who developed a malignant breast nodule and, after surgery, showed a severe intolerance to chemotherapy."
        }
      ],
      "functional_data": {
        "summary": "The variant produces a frameshift and premature termination of translation.",
        "assays": [
          "chromosome fragility test",
          "HRR activity measurement"
        ]
      },
      "segregation_data": "The variant is found in trans with another BRCA2 variant.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant has been previously described in FA patients and is classified as pathogenic class 5 in ClinVar.",
      "key_quotes": [
        "This variant had previously been described in FA patients and in HBOC patients.",
        "It is reported in ClinVar as pathogenic class 5 classified by the ENIGMA expert panel."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.7796A>G",
      "protein_notation": "p.(Glu2599Gly)",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 1,
        "demographics": "33-year-old female",
        "phenotype": "Fanconi anemia, breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "FA663",
          "age_at_evaluation": 33,
          "age_at_onset": null,
          "age_at_diagnosis": 33,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with Fanconi anemia after chemotherapy reaction",
          "evidence_sentence": "Patient FA663 was a thirty-three-year-old woman who developed a malignant breast nodule and, after surgery, showed a severe intolerance to chemotherapy."
        }
      ],
      "functional_data": {
        "summary": "The missense variant is predicted to be deleterious and provides partial HRR activity.",
        "assays": [
          "HRR activity measurement",
          "RAD51 foci formation"
        ]
      },
      "segregation_data": "The variant is found in trans with another BRCA2 variant.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is classified as of uncertain significance according to ACMG guidelines.",
      "key_quotes": [
        "A second missense variant c.7796 A > G, p.(Glu2599Gly) was identified in BRCA2 exon 16 and classified as of 'uncertain significance' according to the ACMG guidelines.",
        "The p.(Glu2599Gly) is predicted deleterious for BRASS NN (score 0.912 pathogenic), BRASS MLR (score 1.675 pathogenic), AGVGD (Class C65), PolyPhen-2 (score 1 probably damaging) and SIFT (score 0.01 predict non-tolerated) in silico tools."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}